A Study of the Combination of Raltitrexed and Irinotecan Every Two Weeks as 2nd Line Treatment of Metastatic Colorectal Cancer

ABSTRACT: Interventions: Controlled:Raltitrexed and Irinotecan Primary outcome(s): Progression Free Survival Study Design: historical control

DISEASE(S): Colorectal Cancer

PROVIDER: 2668813 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR